Further to the Written answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA, how many patients who had been exposed to agrochemicals were seen and treated by the specialist registrar at the Medical Toxicology Unit; whether they were informed of the source of funding for the specialist...

Further to the Written answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA, how many patients who had been exposed to agrochemicals were seen and treated by the specialist registrar at the Medical Toxicology Unit; whether they were informed of the source of funding for the specialist...

Whether the agrochemical company Syngenta (then Zeneca) was given access to the medical records of patients who had attended the outpatients' clinic of the Medical Toxicology Unit four illnesses related to exposure to pesticides and to National Poisons Information Service inquiry data on pesticide exposure incidents through the specialist registrar...

Whether the agrochemical company Syngenta (then Zeneca) was given access to the medical records of patients who had attended the outpatients' clinic of the Medical Toxicology Unit four illnesses related to exposure to pesticides and to National Poisons Information Service inquiry data on pesticide exposure incidents through the specialist registrar...

Further to the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA, how many whole-time equivalents of the specialist registrar's post part-funded by Syngenta (then Zeneca) were spent dealing with agrochemical toxicology issues) [HL 4407].

Further to the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA, how many whole-time equivalents of the specialist registrar's post part-funded by Syngenta (then Zeneca) were spent dealing with agrochemical toxicology issues) [HL 4407].

How they reconcile the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA with the letter of 4 October 2000 sent by the Parliamentary Under-Secretary of State for Health to Paul Tyler MP in which she stated "the Medical Toxicology Unit provides post marketing surveillance for...

How they reconcile the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA with the letter of 4 October 2000 sent by the Parliamentary Under-Secretary of State for Health to Paul Tyler MP in which she stated "the Medical Toxicology Unit provides post marketing surveillance for...

Further to the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA, whether the possible conflicts of interest between a therapeutic role and the interests of a commercial agrochemical company were addressed by the local Research and Ethics Committee of the Guy's and St Thomas' Hospital...

Further to the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37-8WA, whether the possible conflicts of interest between a therapeutic role and the interests of a commercial agrochemical company were addressed by the local Research and Ethics Committee of the Guy's and St Thomas' Hospital...

Further to the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37WA, whether they will place in the Library of the House a copy of each of the annual returns made by the Medical Toxicology Unit under the Guy's and St Thomas' Hospital Trust's conflict of...

Further to the Written Answer by Lord Hunt of Kings Heath on 7 March, 632 c37WA, whether they will place in the Library of the House a copy of each of the annual returns made by the Medical Toxicology Unit under the Guy's and St Thomas' Hospital Trust's conflict of...

Further to the Written Answer by Lord Hunt of Kings Heath on 15 January 2001, 620 c110WA, how much was the funding for a specialist registrar at the Medical Toxicology Unit, London, by Zeneca (now Syngenta); how much staff time was funded; and for what period. [HL 2762]. - Inc...

Further to the Written Answer by Lord Hunt of Kings Heath on 15 January 2001, 620 c110WA, how much was the funding for a specialist registrar at the Medical Toxicology Unit, London, by Zeneca (now Syngenta); how much staff time was funded; and for what period. [HL 2762]. - Inc...

Whether the Medical Toxicology Unit (MTU) has received funding from any other agrochemical companies; how much funding is the MTU currently receiving from agrochemical companies; and for what purposes. [HL 2763].

Whether the Medical Toxicology Unit (MTU) has received funding from any other agrochemical companies; how much funding is the MTU currently receiving from agrochemical companies; and for what purposes. [HL 2763].

Whether they have information about the number of symptomatic patients who were subject to exposure to organophosphate-containing sheep dips and other organophosphate-containing products who were subjects of a clinical investigation by the Medical Toxicology Unit during 1993. [HL 982]. - Includes figure.

Whether they have information about the number of symptomatic patients who were subject to exposure to organophosphate-containing sheep dips and other organophosphate-containing products who were subjects of a clinical investigation by the Medical Toxicology Unit during 1993. [HL 982]. - Includes figure.

Whether the Medical Toxicology Unit will make the clinical records of the pilot study Surveillance of sheep dip exposures - 23 September to 3 November 1991 available, subject to consent and confidentiality, to independent researchers who are carrying out government-funded research on the effects of organophosphates on health; and whether...

Whether the Medical Toxicology Unit will make the clinical records of the pilot study Surveillance of sheep dip exposures - 23 September to 3 November 1991 available, subject to consent and confidentiality, to independent researchers who are carrying out government-funded research on the effects of organophosphates on health; and whether...

Whether any members of staff employed by the Medical Toxicology Unit (formerly the National Poisons Unit) have a formal qualification in crop protection science or have published research in pesticide-related science; and if so, who they are. [HL 91].

Whether any members of staff employed by the Medical Toxicology Unit (formerly the National Poisons Unit) have a formal qualification in crop protection science or have published research in pesticide-related science; and if so, who they are. [HL 91].

What employment contracts, consultancies (whole or part-time) or liaison arrangements have existed between the agrochemical companies Zeneca and Novartis of their predessors and the Medical Toxicology Unit (formerly the National Poisons Unit) since 1990; and how many of these arrangements are current. [HL 67].

What employment contracts, consultancies (whole or part-time) or liaison arrangements have existed between the agrochemical companies Zeneca and Novartis of their predessors and the Medical Toxicology Unit (formerly the National Poisons Unit) since 1990; and how many of these arrangements are current. [HL 67].

Whether Ethics Committee approval was necessary for any joint staffing arrangements between the Medical Toxicology Unit (formerly the National Poisons Unit) and agrochemical companies. [HL 68].

Whether Ethics Committee approval was necessary for any joint staffing arrangements between the Medical Toxicology Unit (formerly the National Poisons Unit) and agrochemical companies. [HL 68].

Whether they consider that the employment in the outpatients department of the Medical Toxicology Unit (formerly the National Poisons Unit) of a clinical consultant who is also employed by the agrochemical company Syngenta (formerly Zeneca) might lead to a potential conflict of interest in view of the role of the...

Whether they consider that the employment in the outpatients department of the Medical Toxicology Unit (formerly the National Poisons Unit) of a clinical consultant who is also employed by the agrochemical company Syngenta (formerly Zeneca) might lead to a potential conflict of interest in view of the role of the...

How many patients who attended the Medical Toxicology Unit (formerly the National Poisons Unit) were diagnosed by their clinicians as suffering from (a) acute organophosphate poisoning; or (b) chronic organosphosphate poisoning for each year since 1990. [HL 69].

How many patients who attended the Medical Toxicology Unit (formerly the National Poisons Unit) were diagnosed by their clinicians as suffering from (a) acute organophosphate poisoning; or (b) chronic organosphosphate poisoning for each year since 1990. [HL 69].

Whether the pilot study Surveillance of sheep dip exposures 23 September to 3 November 1991 - final report October 1992 received Ethics Committee approval; by whom the study was funded; and what subsequent research on organophosphate poisoning, including a questionnaire survey, has been conducted by Medical Toxicology Unit (formerly the...

Whether the pilot study Surveillance of sheep dip exposures 23 September to 3 November 1991 - final report October 1992 received Ethics Committee approval; by whom the study was funded; and what subsequent research on organophosphate poisoning, including a questionnaire survey, has been conducted by Medical Toxicology Unit (formerly the...

Whether any research conducted by the Medical Toxicology Unit (formerly the National Poisons Unit) into the effects of exposure to organophosphates subsequent to Surveillance of sheep dip exposures 23 September to 3 November 1991 - Final Report October 1992 Murray et al, had Ethics Committee approval; if so, when, by...

Whether any research conducted by the Medical Toxicology Unit (formerly the National Poisons Unit) into the effects of exposure to organophosphates subsequent to Surveillance of sheep dip exposures 23 September to 3 November 1991 - Final Report October 1992 Murray et al, had Ethics Committee approval; if so, when, by...